ID   DCMC_RAT                Reviewed;         492 AA.
AC   Q920F5; Q9WUY2;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   29-MAY-2024, entry version 132.
DE   RecName: Full=Malonyl-CoA decarboxylase, mitochondrial {ECO:0000305};
DE            Short=MCD;
DE            EC=4.1.1.9 {ECO:0000269|PubMed:10229677, ECO:0000269|PubMed:12297032, ECO:0000269|PubMed:16298369};
DE   Flags: Precursor;
GN   Name=Mlycd {ECO:0000312|RGD:620234};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MITOCHONDRIAL), CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10229677; DOI=10.1042/bj3400213;
RA   Voilley N., Roduit R., Vicaretti R., Bonny C., Waeber G., Dyck J.R.,
RA   Lopaschuk G.D., Prentki M.;
RT   "Cloning and expression of rat pancreatic beta-cell malonyl-CoA
RT   decarboxylase.";
RL   Biochem. J. 340:213-217(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MITOCHONDRIAL), PARTIAL PROTEIN
RP   SEQUENCE, FUNCTION, PROTEOLYTIC PROCESSING, AND TISSUE SPECIFICITY.
RX   PubMed=10947976; DOI=10.1042/bj3500599;
RA   Dyck J.R., Berthiaume L.G., Thomas P.D., Kantor P.F., Barr A.J., Barr R.,
RA   Singh D., Hopkins T.A., Voilley N., Prentki M., Lopaschuk G.D.;
RT   "Characterization of rat liver malonyl-CoA decarboxylase and the study of
RT   its role in regulating fatty acid metabolism.";
RL   Biochem. J. 350:599-608(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MITOCHONDRIAL), CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=12297032; DOI=10.5483/bmbrep.2002.35.2.213;
RA   Lee G.Y., Bahk Y.Y., Kim Y.S.;
RT   "Rat malonyl-CoA decarboxylase; cloning, expression in E. coli and its
RT   biochemical characterization.";
RL   J. Biochem. Mol. Biol. 35:213-219(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM MITOCHONDRIAL).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION (ISOFORM CYTOPLASMIC+PEROXISOMAL), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10455107; DOI=10.1074/jbc.274.35.24461;
RA   Sacksteder K.A., Morrell J.C., Wanders R.J.A., Matalon R., Gould S.J.;
RT   "MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase
RT   and is mutated in malonyl-CoA decarboxylase deficiency.";
RL   J. Biol. Chem. 274:24461-24468(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=15105298; DOI=10.1161/01.res.0000129255.19569.8f;
RA   Dyck J.R., Cheng J.F., Stanley W.C., Barr R., Chandler M.P., Brown S.,
RA   Wallace D., Arrhenius T., Harmon C., Yang G., Nadzan A.M., Lopaschuk G.D.;
RT   "Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by
RT   inhibiting fatty acid oxidation and stimulating glucose oxidation.";
RL   Circ. Res. 94:E78-E84(2004).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=16298369; DOI=10.1016/j.febslet.2005.10.050;
RA   Joly E., Bendayan M., Roduit R., Saha A.K., Ruderman N.B., Prentki M.;
RT   "Malonyl-CoA decarboxylase is present in the cytosolic, mitochondrial and
RT   peroxisomal compartments of rat hepatocytes.";
RL   FEBS Lett. 579:6581-6586(2005).
RN   [8]
RP   ACETYLATION AT LYS-58; LYS-167; LYS-210; LYS-316; LYS-388 AND LYS-441, AND
RP   MUTAGENESIS OF LYS-210; LYS-308 AND LYS-388.
RX   PubMed=16739991; DOI=10.1021/pr050487g;
RA   Nam H.W., Lee G.Y., Kim Y.S.;
RT   "Mass spectrometric identification of K210 essential for rat malonyl-CoA
RT   decarboxylase catalysis.";
RL   J. Proteome Res. 5:1398-1406(2006).
CC   -!- FUNCTION: Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In the
CC       fatty acid biosynthesis MCD selectively removes malonyl-CoA and thus
CC       assures that methyl-malonyl-CoA is the only chain elongating substrate
CC       for fatty acid synthase and that fatty acids with multiple methyl side
CC       chains are produced. In peroxisomes it may be involved in degrading
CC       intraperoxisomal malonyl-CoA, which is generated by the peroxisomal
CC       beta-oxidation of odd chain-length dicarboxylic fatty acids. Plays a
CC       role in the metabolic balance between glucose and lipid oxidation in
CC       muscle independent of alterations in insulin signaling. May play a role
CC       in controlling the extent of ischemic injury by promoting glucose
CC       oxidation. {ECO:0000269|PubMed:10947976, ECO:0000269|PubMed:15105298,
CC       ECO:0000269|PubMed:16298369}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + malonyl-CoA = acetyl-CoA + CO2; Xref=Rhea:RHEA:18781,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57384; EC=4.1.1.9; Evidence={ECO:0000269|PubMed:10229677,
CC         ECO:0000269|PubMed:12297032, ECO:0000269|PubMed:16298369};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18782;
CC         Evidence={ECO:0000305};
CC   -!- ACTIVITY REGULATION: Malonyl-CoA decarboxylase activity does not
CC       require any cofactors or divalent metal ions.
CC       {ECO:0000250|UniProtKB:O95822}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.36 mM for malonyl-CoA {ECO:0000269|PubMed:12297032};
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA biosynthesis;
CC       acetyl-CoA from malonyl-CoA: step 1/1.
CC   -!- SUBUNIT: Homotetramer. Dimer of dimers. The two subunits within a dimer
CC       display conformational differences suggesting that at any given moment,
CC       only one of the two subunits is competent for malonyl-CoA binding and
CC       catalytic activity. Under oxidizing conditions, can form disulfide-
CC       linked homotetramers (in vitro). Associates with the peroxisomal
CC       targeting signal receptor PEX5 (By similarity).
CC       {ECO:0000250|UniProtKB:O95822}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16298369}.
CC       Mitochondrion matrix {ECO:0000269|PubMed:16298369}. Peroxisome
CC       {ECO:0000250}. Peroxisome matrix {ECO:0000269|PubMed:16298369}.
CC       Note=Enzymatically active in all three subcellular compartments.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC         Comment=According to PubMed:10229677, a single transcription start
CC         site has been demonstrated.;
CC       Name=Mitochondrial;
CC         IsoId=Q920F5-1; Sequence=Displayed;
CC       Name=Cytoplasmic+peroxisomal;
CC         IsoId=Q920F5-2; Sequence=VSP_018818;
CC   -!- TISSUE SPECIFICITY: Expressed in liver, heart, skeletal muscles and
CC       adipose tissues (at protein level). Ubiquitous. Strongly expressed in
CC       liver, kidney, heart, skeletal muscle and adipose tissues. Weakly
CC       expressed in brain. {ECO:0000269|PubMed:10229677,
CC       ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:10947976,
CC       ECO:0000269|PubMed:12297032}.
CC   -!- PTM: Acetylation at Lys-471 activates malonyl-CoA decarboxylase
CC       activity. Deacetylation at Lys-471 by SIRT4 represses activity, leading
CC       to promote lipogenesis (By similarity). {ECO:0000250|UniProtKB:Q99J39}.
CC   -!- PTM: Interchain disulfide bonds may form in peroxisomes (Potential).
CC       Interchain disulfide bonds are not expected to form in the reducing
CC       environment of the cytoplasm and mitochondria. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform Cytoplasmic+peroxisomal]: May be produced by
CC       alternative initiation at Met-39 of isoform mitochondrial.
CC       Alternatively, represents a proteolytic processed form of the
CC       mitochondrial form (PubMed:10947976). {ECO:0000305|PubMed:10947976}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ007704; CAB46681.1; -; mRNA.
DR   EMBL; AF304865; AAL09352.1; -; mRNA.
DR   EMBL; BC061845; AAH61845.1; -; mRNA.
DR   RefSeq; NP_445929.1; NM_053477.1. [Q920F5-1]
DR   AlphaFoldDB; Q920F5; -.
DR   SMR; Q920F5; -.
DR   IntAct; Q920F5; 1.
DR   STRING; 10116.ENSRNOP00000019923; -.
DR   iPTMnet; Q920F5; -.
DR   PhosphoSitePlus; Q920F5; -.
DR   jPOST; Q920F5; -.
DR   PaxDb; 10116-ENSRNOP00000019923; -.
DR   ABCD; Q920F5; 4 sequenced antibodies.
DR   Ensembl; ENSRNOT00000019923.6; ENSRNOP00000019923.3; ENSRNOG00000014522.6. [Q920F5-1]
DR   Ensembl; ENSRNOT00055035328; ENSRNOP00055028634; ENSRNOG00055020693. [Q920F5-1]
DR   Ensembl; ENSRNOT00060041041; ENSRNOP00060033970; ENSRNOG00060023704. [Q920F5-1]
DR   GeneID; 85239; -.
DR   KEGG; rno:85239; -.
DR   UCSC; RGD:620234; rat. [Q920F5-1]
DR   AGR; RGD:620234; -.
DR   CTD; 23417; -.
DR   RGD; 620234; Mlycd.
DR   eggNOG; KOG3018; Eukaryota.
DR   GeneTree; ENSGT00390000005410; -.
DR   HOGENOM; CLU_023433_0_0_1; -.
DR   InParanoid; Q920F5; -.
DR   OMA; PIDWSTP; -.
DR   OrthoDB; 318256at2759; -.
DR   PhylomeDB; Q920F5; -.
DR   TreeFam; TF312959; -.
DR   BRENDA; 4.1.1.9; 5301.
DR   Reactome; R-RNO-390247; Beta-oxidation of very long chain fatty acids.
DR   Reactome; R-RNO-9033241; Peroxisomal protein import.
DR   SABIO-RK; Q920F5; -.
DR   UniPathway; UPA00340; UER00710.
DR   PRO; PR:Q920F5; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000014522; Expressed in heart and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0050080; F:malonyl-CoA decarboxylase activity; IDA:RGD.
DR   GO; GO:0006085; P:acetyl-CoA biosynthetic process; IDA:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0019395; P:fatty acid oxidation; IDA:RGD.
DR   GO; GO:2001294; P:malonyl-CoA catabolic process; ISS:UniProtKB.
DR   GO; GO:0046321; P:positive regulation of fatty acid oxidation; ISS:UniProtKB.
DR   GO; GO:0031998; P:regulation of fatty acid beta-oxidation; IDA:RGD.
DR   GO; GO:0046320; P:regulation of fatty acid oxidation; IMP:RGD.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB.
DR   GO; GO:0002931; P:response to ischemia; IMP:UniProtKB.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   Gene3D; 3.40.630.150; Malonyl-CoA decarboxylase, catalytic domain; 1.
DR   Gene3D; 1.20.140.90; Malonyl-CoA decarboxylase, oligemerization domain; 1.
DR   InterPro; IPR038917; Malonyl_CoA_deC.
DR   InterPro; IPR007956; Malonyl_CoA_deC_C.
DR   InterPro; IPR042303; Malonyl_CoA_deC_C_sf.
DR   InterPro; IPR035372; MCD_N.
DR   InterPro; IPR038351; MCD_N_sf.
DR   PANTHER; PTHR28641; -; 1.
DR   PANTHER; PTHR28641:SF1; MALONYL-COA DECARBOXYLASE, MITOCHONDRIAL; 1.
DR   Pfam; PF05292; MCD; 1.
DR   Pfam; PF17408; MCD_N; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Cytoplasm; Decarboxylase;
KW   Direct protein sequencing; Disulfide bond; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Lyase;
KW   Mitochondrion; Peroxisome; Reference proteome; Transit peptide.
FT   TRANSIT         1..38
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           39..492
FT                   /note="Malonyl-CoA decarboxylase, mitochondrial"
FT                   /id="PRO_0000021092"
FT   REGION          39..189
FT                   /note="Alpha-helical domain"
FT                   /evidence="ECO:0000250"
FT   REGION          190..492
FT                   /note="Catalytic domain"
FT                   /evidence="ECO:0000250"
FT   MOTIF           490..492
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        328
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        422
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   BINDING         298..304
FT                   /ligand="malonyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57384"
FT                   /evidence="ECO:0000250"
FT   BINDING         328
FT                   /ligand="malonyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57384"
FT                   /evidence="ECO:0000250"
FT   BINDING         422
FT                   /ligand="malonyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57384"
FT                   /evidence="ECO:0000250"
FT   SITE            210
FT                   /note="Essential for catalytic activity"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MOD_RES         167
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J39"
FT   MOD_RES         167
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J39"
FT   MOD_RES         210
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MOD_RES         221
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J39"
FT   MOD_RES         316
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MOD_RES         385
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J39"
FT   MOD_RES         385
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J39"
FT   MOD_RES         388
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MOD_RES         441
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MOD_RES         471
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J39"
FT   DISULFID        205
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..38
FT                   /note="Missing (in isoform Cytoplasmic+peroxisomal)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018818"
FT   MUTAGEN         210
FT                   /note="K->M: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MUTAGEN         308
FT                   /note="K->M: 40% reduction in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   MUTAGEN         388
FT                   /note="K->M: 40% reduction in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16739991"
FT   CONFLICT        213
FT                   /note="E -> D (in Ref. 1; CAB46681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        218
FT                   /note="H -> Q (in Ref. 1; CAB46681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        301
FT                   /note="E -> G (in Ref. 1; CAB46681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        412
FT                   /note="Missing (in Ref. 1; CAB46681)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   492 AA;  54762 MW;  D1FB65533B5A582E CRC64;
     MRGLGPSLRA RRLLPLRYPP RPPGPRGPRL CSGLTASAMD ELLRRAVPPT PAYELREKTP
     APAEGQCADF VSFYGGLAEA AQRAELLGRL AQGFGVDHGQ VAEQSAGVLQ LRQQSREAAV
     LLQAEDRLRY ALVPRYRGLF HHISKLDGGV RFLVQLRADL LEAQALKLVE GPHVREMNGV
     LKSMLSEWFS SGFLNLERVT WHSPCEVLQK ISECEAVHPV KNWMDMKRRV GPYRRCYFFS
     HCSTPGDPLV VLHVALTGDI SNNIQSIVKE CPPSETEEKN RIAAAVFYSI SLTQQGLQGV
     ELGTFLIKRV VKELQKEFPH LGAFSSLSPI PGFTKWLLGL LNVQGKEYGR NELFTDSECK
     EIAEVTGDPV HESLKGLLSS GEWAKSEKLA QALQGPLMRL CAWYLYGEKH RGYALNPVAN
     FHLQNGAVMW RINWMADSSL KGLTSSCGLM VNYRYYLEET GPNSISYLGS KNIKASEQIL
     SLVAQFQSNS KL
//
